Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 4:25 pm Sale |
2024-12-31 | 13G | TherapeuticsMD, Inc. TXMD |
Clearline Capital LP | 635,222 5.500% |
-1,400 (-0.22%) |
Filing History |
| 2024-11-12 4:40 pm Purchase |
2024-09-30 | 13G | TherapeuticsMD, Inc. TXMD |
Clearline Capital LP | 636,622 5.520% |
636,622 (New Position) |
Filing History |
| 2023-11-17 09:28 am Purchase |
2023-11-15 | 13D | TherapeuticsMD, Inc. TXMD |
Rubric Capital Management LP | 2,946,908 25.730% |
877,192 (+42.38%) |
Filing History |
| 2023-06-30 08:29 am Purchase |
2023-06-28 | 13D | TherapeuticsMD, Inc. TXMD |
Rubric Capital Management LP | 2,069,716 19.570% |
347,763 (+20.20%) |
Filing History |
| 2022-08-30 09:09 am Unchanged |
2022-08-23 | 13D | TherapeuticsMD, Inc. TXMD |
Rubric Capital Management LP | 1,721,953 18.270% |
0 (Unchanged) |
Filing History |
| 2022-08-08 4:42 pm Purchase |
2022-08-04 | 13D | TherapeuticsMD, Inc. TXMD |
Rubric Capital Management LP | 1,721,953 18.270% |
1,721,953 (New Position) |
Filing History |
| 2022-07-08 4:52 pm Purchase |
2022-06-30 | 13G | TherapeuticsMD, Inc. TXMD |
BLACKROCK INC BLK |
122,138 1.400% |
122,138 (New Position) |
Filing History |
| 2022-06-03 4:39 pm Purchase |
2022-05-31 | 13G | TherapeuticsMD, Inc. TXMD |
Beryl Capital Management LLC | 126,229 1.500% |
126,229 (New Position) |
Filing History |
| 2022-03-23 4:17 pm Purchase |
2022-03-23 | 13D | TherapeuticsMD, Inc. TXMD |
SMITH ROBERT J | 462,066 5.380% |
263,292 (+132.46%) |
Filing History |
| 2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | TherapeuticsMD, Inc. TXMD |
PRICE T ROWE ASSOCIATES INC | 12,996 0.100% |
-364,388 (-96.56%) |
Filing History |
| 2022-01-31 5:49 pm Purchase |
2021-12-31 | 13G | TherapeuticsMD, Inc. TXMD |
BLACKROCK INC BLK |
497,896 5.900% |
69,511 (+16.23%) |
Filing History |
| 2021-07-07 2:02 pm Purchase |
2021-07-02 | 13G | TherapeuticsMD, Inc. TXMD |
Flynn James E | 413,256 4.900% |
413,256 (New Position) |
Filing History |
| 2021-02-16 12:23 pm Sale |
2020-12-31 | 13G | TherapeuticsMD, Inc. TXMD |
PRICE T ROWE ASSOCIATES INC | 377,384 6.200% |
-7,407 (-1.92%) |
Filing History |
| 2021-02-10 11:57 am Sale |
2020-12-31 | 13G | TherapeuticsMD, Inc. TXMD |
The Vanguard Group | 263,313 4.390% |
-68,592 (-20.67%) |
Filing History |
| 2021-02-08 10:33 am Sale |
2021-02-05 | 13G | TherapeuticsMD, Inc. TXMD |
FMR CORP | 282,329 4.709% |
-71,220 (-20.14%) |
Filing History |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | TherapeuticsMD, Inc. TXMD |
BLACKROCK INC BLK |
428,385 7.100% |
63,203 (+17.31%) |
Filing History |
| 2020-12-09 11:54 am Sale |
2020-11-30 | 13G | TherapeuticsMD, Inc. TXMD |
J P MORGAN CHASE & CO JPM |
261,589 4.300% |
-132,772 (-33.67%) |
Filing History |